How Do You Advertise TRT on Meta and Google Without Losing the Account?

How does testosterone's Schedule III status affect TRT advertising?

Testosterone is a Schedule III controlled substance, and two consequences follow for marketing. First, the telemedicine rules for prescribing controlled substances without an in-person visit rest on temporary federal flexibilities that have been extended repeatedly, most recently by the fourth temporary extension, Federal Register document 2025-24123, which runs through December 31, 2026, and state rules layer on top. A plan that depends on those flexibilities needs a date in the diary for that deadline. A TRT brand's visit model, prescriber licensing and pharmacy choice all depend on those rules, and an ad that promises something the model cannot lawfully deliver in a state is a problem larger than a rejected ad.

Second, LegitScript's application asks for DEA certificate information where controlled substances are involved, and its terms bar prescribing without a valid prescription and a legitimate practitioner-patient relationship. A visit model that cannot show both stalls certification, and with it every platform that relies on it. MedScale lists these controlled-substance questions separately in its policy read of a TRT account.

Can you advertise enclomiphene, hCG or peptides alongside TRT?

Not as products. The fertility-preserving alternatives most TRT brands offer are usually compounded, not FDA-approved, and enclomiphene is not an FDA-approved drug at all. On Google they fall under unapproved substances and cannot be advertised; Google's unapproved substances policy also names hCG promoted in conjunction with anabolic steroids, which is exactly how a TRT menu presents it. On Meta they fall under the unapproved-substances reading of the drugs standard. The ad names the program and the provider; enclomiphene is explained on the page after the click, framed as a clinical option the prescriber may consider, with the compounded status stated plainly. Peptides presented as products are a common cause of a men's health account being disabled for unsafe substances. MedScale keeps enclomiphene, hCG and peptides out of TRT ads and keyword lists.

What do TRT ads and landing pages need to pass review?

• Ads show the labs, the visit, the follow-up and the price. Providers speak to camera. No "you" hooks, and, as MedScale's house rule rather than a platform rule, no bodies or before-and-after.
• Drug names stay out of ad text and keyword lists until certification is active on that platform.
• The landing page leads with the program and the lab panel, puts medication options second, and states the controlled-substance and telemedicine requirements in plain language.
• Once certified, the certification seal appears in the footer of every page an ad can land on, and consultation campaigns and authorized-product campaigns never share an ad set, because a campaign is judged by its most regulated product.
• Tracking events are named generically. A pixel event called after testosterone re-tiers the account on its first fire.

Can a TRT brand advertise testosterone on TikTok?

Not as a prescription product. TikTok's Healthcare and Pharmaceuticals policy, last updated September 2026, says prescription medicine ads in the United States may be allowed with proof of approval and certification from the FDA and 18+ targeting; most other markets do not allow them. TikTok's drugs policy also bars controlled drugs, and testosterone is a Schedule III controlled substance, so treat testosterone ads on TikTok as not allowed unless TikTok confirms otherwise in writing. Compounded testosterone, enclomiphene and peptides are not FDA-approved and cannot qualify either way. In practice TikTok stays an awareness channel for the clinic and the provider, or a channel for non-prescription offers, and an operator should not build a direct-response TRT plan around it. MedScale plans TRT accounts on that basis.

How do the clinic layer and the prescription layer run side by side?

On Meta the TRT clinic layer is not a placeholder while certification is pending; it is the durable core of a TRT account. Meta campaigns on the lab-first offer and the prescriber keep running after certification arrives, and once Google's certification is in place, search campaigns on treatment intent join them. What Meta's authorization adds is a second set of campaigns, in their own ad sets, that may name the prescription products. Keeping the two layers separate is not tidiness: a campaign is judged by its most regulated product, so a single authorized-product ad in a consultation ad set drags the whole set under the prescription rules.

Layer separation applies to the landing pages too, and MedScale builds a separate page for each layer. The page a clinic-layer ad lands on leads with the lab panel, the visit and the follow-up cadence; the page an authorized-product ad lands on may name the products, with the certification seal in the footer and the compounded status of any compounded product stated plainly. A landing page that does both jobs at once tends to fail both reviews.

What should a TRT telehealth brand measure?

The metric that decides a TRT campaign is not cost per lead but cost per qualified lead, defined as a lab ordered or an intake completed with a state the brand can serve, and then the consult booked, the prescription issued and the patient still shipping at month three. Those events happen in the intake platform and the pharmacy system, not on the website, so the ad click has to travel with the patient into those systems and the events have to come back server-side with generic names. A brand that reports form fills to Meta and Google is optimizing toward the men who abandon at the lab step, which is the most expensive place in the funnel to be wrong. MedScale reports TRT results as cost per qualified lead through prescriptions issued, by state and campaign.

How does MedScale run Meta and Google ads for TRT telehealth brands?

MedScale Health runs TRT telehealth acquisition as described on medscale.health/telehealth/trt-mens-health: a policy read of every ad, page and pixel event with the controlled-substance questions listed separately, server-side tracking that carries the ad click through labs, the visit and the prescription, lab-first campaigns on Meta and, once certified, Google, and weekly reporting of cost per qualified lead through prescriptions issued by state and campaign. The LegitScript and Google filings start on day one; Meta's clinic layer runs while they are pending.